|
Cancer rate per 100,000 (age-adjusted)
|
141.8 (Deschutes Co.)
|
138.7
|
125.3
|
|
Localized cancer
|
69%
(99 patients)
|
69%
(112 patients)
|
not available
|
63%
|
|
Regional cancer
|
26%
(37 patients)
|
27%
(43 patients)
|
not available
|
30%
|
|
Distant cancer
|
5%
(7 patients)
|
4%
(7 patients)
|
not available
|
6%
|
|
Unstaged cancers
|
0%
(0 patients)
|
0%
(0 patients)
|
not available
|
2%
|
|
Total patients
|
143
|
162
|
not available
|
not applicable*
|
|
Radiation therapy is administered within 365 days of diagnosis for women under age 70 receiving breast-conserving surgery for breast cancer.
|
100%
|
100%
|
not available
|
not available
|
|
Combination chemotherapy is considered or administered within 120 days of diagnosis for women under age 70 with AJCC T1cN0M0, or Stage II or III hormone receptor negative breast cancer.
|
100%
|
100%
|
not available
|
not available
|
|
Tamoxifen or third generation aromatase inhibitor is considered or administered within 365 days of diagnosis for women with AJCC T1cN0M0, or Stage II or III hormone receptor positive breast cancer.
|
100%
|
98%
|
not available
|
not available
|
|
Localized cancer
|
100%
(of 419 patients)
|
not available
|
98%
|
|
Regional cancer
|
84%
(of 216 patients)
|
not available
|
83%
|
|
Distant cancer
|
34%
(of 25 patients)
|
not available
|
28%
|
|
Unstaged cancers
|
(0 patients)
|
|
not available
|
56%
|
|
All stages combined
|
94%
(of 660 patients)
|
not available
|
89%
|
|
Cancer rate per 100,000 (age-adjusted)
|
51.4 (Deschutes Co.)
|
48.0
|
52.9
|
|
Localized cancer
|
34%
(26 patients)
|
40%
(37 patients)
|
not available
|
40%
|
|
Regional cancer
|
44%
(34 patients)
|
39%
(36 patients)
|
not available
|
37%
|
|
Distant cancer
|
18%
(14 patients)
|
18%
(17 patients)
|
not available
|
19%
|
|
Unstaged cancers
|
4%
(3 patients)
|
2%
(2 patients)
|
not available
|
4%
|
|
Total patients
|
77
|
92
|
not available
|
not applicable*
|
|
Adjuvant chemotherapy is considered or administered within 120 days of diagnosis for patients under the age of 80 with AJCC Stage III (lymph node positive) colon cancer.
|
100%
|
100%
|
not available
|
not available
|
|
SURVIVAL: Relative five-year survival by stage at diagnosis**
|
Diagnosed 1998-2003
|
Diagnosed 1998-2003
|
|
Localized cancer
|
94%
(of 148 patients)
|
not available
|
90%
|
|
Regional cancer
|
79%
(of 262 patients)
|
not available
|
69%
|
|
Distant cancer
|
9%
(of 108 patients)
|
|
not available
|
10%
|
|
Unstaged cancers
|
34%
(of 10 patients)
|
|
not available
|
37%
|
|
All stages combined
|
67%
(of 528 patients)
|
not available
|
65%
|
|
Cancer rate per 100,000 (age-adjusted)
|
236.3 (Deschutes Co.)
|
156.1
|
162.1
|
|
Localized/regional cancer
|
96%
(159 patients)
|
95%
(175 patients)
|
not available
|
92%
|
|
Distant cancer
|
4%
(6 patients)
|
5%
(9 patients)
|
not available
|
5%
|
|
Unstaged cancers
|
0%
(0 patients)
|
0%
(0 patients)
|
not available
|
3%
|
|
Total patients
|
165
|
184
|
not available
|
not applicable*
|
|
Localized/regional cancer
|
100%
(of 854 patients)
|
not available
|
100%
|
|
Distant cancer
|
16%
(of 18 patients)
|
|
not available
|
32%
|
|
Unstaged cancers
|
100%
(of 6 patients)
|
|
not available
|
80%
|
|
All stages combined
|
100%
(of 878 patients)
|
not available
|
99%
|
|
Cancer rate per 100,000 (age-adjusted)
|
61.9 (Deschutes Co.)
|
69.0
|
69.2
|
|
Localized cancer
|
26%
(32 patients)
|
30%
(32 patients)
|
not available
|
16%
|
|
Regional cancer
|
29%
(35 patients)
|
34%
(36 patients)
|
not available
|
35%
|
|
Distant cancer
|
45%
(55 patients)
|
36%
(38 patients)
|
not available
|
42%
|
|
Unstaged cancers
|
0%
(0 patients)
|
0%
(0 patients)
|
not available
|
7%
|
|
Total patients
|
122
|
106
|
not available
|
not applicable*
|
|
Localized cancer
|
49%
(of 116 patients)
|
not available
|
50%
|
|
Regional cancer
|
19%
(of 219 patients)
|
not available
|
16%
|
|
Distant cancer
|
3%
(of 278 patients)
|
not available
|
3%
|
|
Unstaged cancers
|
8%
(of 19 patients)
|
|
not available
|
9%
|
|
All stages combined
|
17%
(of 632 patients)
|
not available
|
16%
|